Adult Study Oxytocin - fMRI

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

59

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

September 30, 2017

Study Completion Date

September 30, 2017

Conditions
SchizophreniaOxytocinSocial CognitionFunctional Magnetic Resonance Imaging (fMRI)
Interventions
DRUG

Oxytocin

40 IU of the oxytocin will be administered intranasally for a one time dose at the beginning of the visit.

DRUG

Saline Nasal Spray

40 IU of the saline nasal spray will be administered once at the beginning of the visit.

Trial Locations (2)

94121

San Francisco Veterans Affairs Medical Center, San Francisco

94143

University of California, San Francisco, San Francisco

All Listed Sponsors
collaborator

San Francisco Veterans Affairs Medical Center

FED

lead

University of California, San Francisco

OTHER

NCT02566356 - Adult Study Oxytocin - fMRI | Biotech Hunter | Biotech Hunter